BEAM CIK: 1745999

Beam Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
1.27
FY22:
1.09
FY23:
1.21
FY24:
0.88
FY25:
1.27
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.20
FY22:
0.25
FY23:
0.25
FY24:
0.23
FY25:
0.21
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.47
FY22:
1.34
FY23:
1.46
FY24:
1.10
FY25:
1.48

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.21
FY22:
0.22
FY23:
0.21
FY24:
0.18
FY25:
0.10
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.43
FY22:
0.38
FY23:
0.27
FY24:
0.19
FY25:
0.15
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.83
FY22:
0.73
FY23:
0.98
FY24:
0.73
FY25:
1.24
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.47
FY22:
1.34
FY23:
1.46
FY24:
1.10
FY25:
1.48

All amounts in billions USD Data source:SEC EDGAR